Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 3/20 | 0.45 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8890271 | 0.99 | SLC2A1 (0.47) | SLC2A1NPY5RNPC1TP53PKM | |
| SCHEMBL8891834 | 0.87 | SLC2A1 (0.44) | SLC2A1 | |
| Hydrochloric Acid SCHEMBL8889266 | 0.86 | SLC2A1 (0.46) | SLC2A1 | |
| SCHEMBL8891387 | 0.76 | NPY5R (0.69) | SLC2A1NPY5R | |
| Hydrochloric Acid SCHEMBL8890265 | 0.76 | NPY5R (0.67) | SLC2A1NPY5R | |
| SCHEMBL8891648 | 0.76 | NPY5R (0.41) | SLC2A1NPY5R | |
| SCHEMBL8890917 | 0.75 | NPY5R (0.65) | SLC2A1NPY5RNPC1TP53RAB9A | |
| SCHEMBL8890695 | 0.74 | SLC2A1 (0.51) | SLC2A1NPY5RNPC1TP53PKM | |
| Hydrochloric Acid SCHEMBL8889736 | 0.74 | NPY5R (0.63) | SLC2A1NPY5RNPC1TP53RAB9A | |
| Hydrochloric Acid SCHEMBL8890337 | 0.74 | SLC2A1 (0.50) | SLC2A1NPY5RNPC1TP53PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1997020822-A1 | QUINAZOLIN-2,4-DIAZIRINES AS NPY RECEPTOR ANTAGONIST | NOVARTIS AG (CH) | 1997-06-12 | — | — | WO | claimed |